🔎 Trials Near Me

Home › Pneumococcal Infections › Alabama › Birmingham

Pneumococcal Infections clinical trials in Birmingham, AL

4 studies for Pneumococcal Infections are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults

RecruitingPhase 3Healthy volunteers welcome
  • Achieve Clinical Research, LLC d/b/a Accel Research Sites - Birmingham Clinical Research Unit, Birmingham
Ages 18 to 49 · All sexes · Updated Sep 23, 2026 · NCT07794748

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

RecruitingPhase 3Healthy volunteers welcome
  • Alabama Clinical Therapeutics, LLC Birmingham Pediatric Associates, Birmingham
  • University of Alabama at Birmingham - School of Medicine, Birmingham
42 Days – 211 Days · All sexes · Updated Sep 8, 2026 · NCT07629440

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

RecruitingPhase 3Healthy volunteers welcome
  • Alabama Clinical Therapeutics, LLC Birmingham Pediatric Associates, Birmingham
  • UAB Child Health Research Unit (CHRU), Birmingham
15 Months – 17 Years · All sexes · Updated Aug 31, 2026 · NCT07660198

Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines

RecruitingPhase 4Healthy volunteers welcome
  • University of Alabama at Birmingham, Birmingham
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07135453

About Pneumococcal Infections

Pneumococcal infections can be mild or severe. The most common types of infections are Meningitis, Sepsis, Pneumonia, and ear and sinus infections

More about Pneumococcal Infections on MedlinePlus

Pneumococcal Infections trials in other cities

Other studies in Birmingham

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.